Symptoms of ocular rosacea may include only “a dry, gritty feel” to the eye and a red eyelid margin, according to ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally adv ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

A doctor has offered guidance on managing a common skin condition that often worsens during the colder months. Sharing advice ...

According to the NHS, rosacea is a long-term skin condition that can cause redness, dry skin, and swelling, and it can be ...

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 ...

Slapped cheek disease also called fifth disease is a contagious viral infection common in children Read to know all about the ...

In addition to its effect on reducing Demodex in patients with rosacea, topical ivermectin may improve symptoms by changing the skin microbiome.

Discover a study regime that included a treatment serum, a redness-reducing moisturizer, and sunscreen that showed promising ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...